0001179110-19-010493.txt : 20190919 0001179110-19-010493.hdr.sgml : 20190919 20190919162918 ACCESSION NUMBER: 0001179110-19-010493 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190918 FILED AS OF DATE: 20190919 DATE AS OF CHANGE: 20190919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Komjathy Andrew CENTRAL INDEX KEY: 0001788465 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 191102019 MAIL ADDRESS: STREET 1: CATABASIS PHARMACEUTICALS, INC. STREET 2: ONE KENDALL SQUARE, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2019-09-18 0 0001454789 CATABASIS PHARMACEUTICALS INC CATB 0001788465 Komjathy Andrew C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ, BLDG 1400E, STE B14202 CAMBRIDGE MA 02139 0 1 0 0 Chief Commercial Officer Stock Option (right to buy) 5.92 2019-09-18 4 A 0 44500 0 A 2029-09-17 Common Stock 44500 44500 D This option was granted on September 18, 2019 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of September 18, 2019 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month. /s/ Deirdre A. Cunnane, as Attorney-in-fact for Andrew Komjathy 2019-09-19